|
|
|
Volumn 8, Issue 12, 2012, Pages 1743-
|
|
Ovarian cancer vaccine candidate DPX-Survivac: positive interim results from phase 1.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER VACCINE;
CYCLOPHOSPHAMIDE;
IMMUNOLOGIC FACTOR;
FEMALE;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
METHODOLOGY;
NOTE;
OVARY TUMOR;
PHASE 1 CLINICAL TRIAL (TOPIC);
OVARIAN NEOPLASMS;
CANCER VACCINES;
CLINICAL TRIALS, PHASE I AS TOPIC;
CYCLOPHOSPHAMIDE;
FEMALE;
HUMANS;
IMMUNOLOGIC FACTORS;
IMMUNOTHERAPY;
OVARIAN NEOPLASMS;
|
|
EID: 84892523390
PISSN: None
EISSN: 2164554X
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|
